Oral quinine in ankylosing spondylitis: A randomized placebo controlled double blind crossover trial [7]

Journal of Rheumatology

Volumn 27, Issue 8, 2000, Pages 2054-2055

  Williamson, L ^a   Illingworth, H ^a   Smith, D ^a   Mowat, A ^a  

^a NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

QUININE;

ADULT; ANKYLOSING SPONDYLITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; LETTER; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANALGESICS, NON-NARCOTIC; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; NECK PAIN; QUININE; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 0033849628     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Antimalarial drugs in the treatment of rheumatic diseases
2. Quinine
3. Quinine for nocturnal cramps?
4. A new approach to defining disease status in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Disease Activity Index
5. A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index
6. Defining spinal mobility in ankylosing spondylitis: The Bath Ankylosing Spondylitis Metrology Index
7. Low dose amitriptyline in ankylosing spondylitis: A short term, double blind, placebo controlled study
8. The two-period cross-over clinical trial